FindTrial
Sign In

Multicenter observational study to assess cervical cancer and precancerous lesion attributable risk to HPVs in the last decade, in China

Multicenter observational study to assess cervical cancer and precancerous lesion attributable risk to HPVs in the last decade, in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068955
Enrollment
Unknown
Registered
2023-03-02
Start date
2023-03-02
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer and precancerous

Interventions

Precancerous lesion cytology test group:None
Cervical cancer case transcription group:None

Sponsors

School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult female aged >=18 years; 2. First diagnosed with precancerous lesions (CIN) or cervical cancer (SCC and ADC) between 2011 and 2022.

Exclusion criteria

Exclusion criteria: 1. The pathological type is unclear; 2. Sample volume is not sufficient for HPV testing.

Design outcomes

Primary

MeasureTime frame
Human papillomavirus genotypes;Cervical exfoliative cell morphology;Histopathological types of the uterine cervix;—

Secondary

MeasureTime frame
Height;Weight;Age;Ethnic group;Cervical cancer FIGO stage;—

Countries

China

Contacts

Public ContactQiao Youlin

School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College

qiaoy@cicams.ac.cn+86 10 87788489

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026